GANGLIONIC BLOCKING AGENTS
\ɡˌaŋɡlɪˈɒnɪk blˈɒkɪŋ ˈe͡ɪd͡ʒənts], \ɡˌaŋɡlɪˈɒnɪk blˈɒkɪŋ ˈeɪdʒənts], \ɡ_ˌa_ŋ_ɡ_l_ɪ__ˈɒ_n_ɪ_k b_l_ˈɒ_k_ɪ_ŋ ˈeɪ_dʒ_ə_n_t_s]\
Sort: Oldest first
-
Agents having as their major action the interruption of neural transmission at nicotinic receptors on postganglionic autonomic neurons. Because their actions are so broad, including blocking of sympathetic and parasympathetic systems, their therapeutic use has been largely supplanted by more specific drugs. They may still be used in the control of blood pressure in patients with acute dissecting aortic aneurysm and for the induction of hypotension in surgery.
By DataStellar Co., Ltd
Word of the day
Proto Oncogene Proteins c erbB 2
- cell surface protein-tyrosine kinase that is found to be overexpressed in significant number adenocarcinomas. It has extensive homology can heterodimerize EGF EPIDERMAL GROWTH FACTOR), 3 receptor (RECEPTOR, 3) and the 4 receptor. Activation of erbB-2 receptor occurs during heterodimer formation with a ligand-bound erbB family members. EC 2.7.11.-.